Galmed Pharma (GLMD) Reports Q4 Loss of $0.40/Share
Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.40), versus ($0.29) reported last year.
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.
Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.40), versus ($0.29) reported last year.
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.